Morquio Syndrome (MPS-IV) Drug Industry: New Drug Shows Promise for Treating
Morquio syndrome, also known as mucopolysaccharidosis type IV (MPS-IV), is a rare genetic disorder that is part of a group of eleven lysosomal storage diseases known as mucopolysaccharidoses (MPS diseases). It is caused by deficiency of the enzyme N-acetylgalactosamine-6-sulfatase (GALNS), which is responsible for the breakdown of glycosaminoglycans (GAGs) known as keratan sulfate and...
0 التعليقات 0 المشاركات 160 مشاهدة 0 معاينة
إعلان مُمول